Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07565727 · ClinicalTrials.gov registry record
Cardiometabolic Disease and Substrate Metabolism
A clinical trial, sponsored by University of Tennessee Graduate School of Medicine.
- Recruiting
- Registry status
- 50
- Enrollment target
NCT07565727: Recruiting study, sponsored by University of Tennessee Graduate School of Medicine.
NCT07565727 is a clinical trial that is actively recruiting participants, run by University of Tennessee Graduate School of Medicine. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07565727 is actively recruiting participants, sponsored by University of Tennessee Graduate School of Medicine.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
Study Summary
This study's primary purpose is to determine the potential relationship between cardiometabolic disease, specifically insulin resistance (HOMA-IR), and maternal lipid oxidation.
Primary Outcome
Early pregnancy fasting insulin level (mIU/mL) in venous blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-12-10 |
| Est. Completion | 2027-08 |
What NCT07565727 shows while recruiting
NCT07565727 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT07565727 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07565727 about?
NCT07565727 is a clinical study titled "Cardiometabolic Disease and Substrate Metabolism". This study's primary purpose is to determine the potential relationship between cardiometabolic disease, specifically insulin resistance (HOMA-IR), and maternal lipid oxidation.
What is the current status of trial NCT07565727?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-12-10. Estimated completion is 2027-08.
Who is sponsoring clinical trial NCT07565727?
This trial is sponsored by University of Tennessee Graduate School of Medicine, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI